Rock Health News

 

Making any medicine precision medicine: Welcome, InsightRX!

We’re proud to announce our participation in InsightRX’s $10M Series A funding round to support their mission of individualizing drug treatment at the point of care.

Innovation and collaboration in the new age of consumer healthcare: A Q&A with GSK

As consumers increasingly take control of their own health and wellness, they drive market demand more directly. Devices, apps, and services are being created and tailored to meet their needs, enabling consumers to actively engage in health and wellness decision-making. To dig a little deeper beneath the surface of how industry players are adapting to this shift, we caught up with experts on the inside at GSK Consumer Healthcare, a Rock Health partner.

7 reasons why you should attend Rock Health Summit 2019

‘Tis the season of startup pitches, inspirational conversations, and even dance offs. You know what we’re talking about—the eighth annual Rock Health Summit is just over a month away. Here are seven agenda highlights we’re most excited for at this year’s Summit.

Better health, gut first: Our investment in Vivante Health

We’re proud to announce our newest investment in Vivante Health, the first all-in-one digital solution for digestive health and complex inflammatory conditions. Welcome, Vivante!

Funding 7/1/19

2019 Midyear Digital Health Market Update: Exits are heating up

$4.2B was invested in digital health through the first half of 2019. The sector continues to experience healthy growth—we still don’t see the telltale signs of an investment bubble. Here we take stock of the capital invested in digital health startups since 2011—$29.4B of which is waiting on liquidity. We examine two avenues to return this capital: public offerings and acquisition by large non-healthcare companies.

Imagining a world free of diabetic foot ulcers: Our investment in Podimetrics

Since 2012, Podimetrics has worked tirelessly on a remote patient monitoring (RPM) solution to tackle the devastating problem of diabetic foot ulcers. With clinically validated sensor technology and care coordination, Podimetrics is now launching its product to additional commercial payers and at-risk providers. We’re thrilled to announce our participation in Podimetrics’ $13.4M Series B.

Research 4/8/19

Building Pharma-Digital Therapeutic Alliances

Digital therapeutic and pharmaceutical companies are partnering to build, validate, and expand access to new, software-based solutions that improve patient outcomes. This is new territory with few precedents, and the strategies for building successful alliances remain uncertain. Drawing from numerous interviews with digital therapeutic, pharma, and health plan leaders, this research outlines how to overcome execution risks and build successful pharma-digital therapeutic alliances.

Funding 4/1/19

Q1 2019: The end of the digital health IPO drought comes into sight

Coming off a record-smashing year for digital health funding in 2018, we see funding leveling off in the first quarter of 2019. Meanwhile, after a two-and-a-half-year drought, the digital health IPO market is heating up. Here’s the data and our take on how 2019 is shaking out so far for digital health.

Beyond Wellness For the Healthy: Digital Health Consumer Adoption 2018

Results from our fourth national consumer survey (2018 data) on digital health adoption and sentiments. Adoption continues to rise while consumers leverage digital health tools to address concrete health needs.

Funding 1/14/19

2018 Funding Part 2: Seven more takeaways from digital health’s $8.1B year

In a banner year for digital health funding, AI/ML companies raced to the top in dollars raised, investors showed excitement about on-demand healthcare services, and more women CEOs closed rounds than ever before—though they still represent a small sliver of the pie.

Funding 1/7/19

2018 Year End Funding Report: Is digital health in a bubble?

With a record $8.1B in funding and the absence of an equally robust exit market, there is more scrutiny on digital health than ever before. Will value creation track with recent investment trends? To provide some structure around this question, we validated a simple framework with fellow investors to assess the current “bubbliness” of digital health. Our verdict: digital health is not in a bubble.

Other 12/17/18

How an eighty-year-old health plan is building the healthcare model of the future by working with Rock Health

Since 2015, Blue Shield of California has partnered with Rock Health to gain exposure to digital health and elevate its position as an innovative healthcare company. Through its partnership with Rock Health, Blue Shield of California has showcased thought leadership, collaborated on research, and gained unparalleled insight into the frontlines of healthcare innovation.

Diversity 7/23/18

What 600+ women told us about working in healthcare in 2018

Women are critical stakeholders in healthcare, serving as workers, caregivers, and consumers—yet they do not have an equal voice in the ranks of leadership. Our goal with this annual report is to contribute to a meaningful and actionable dialogue around women in leadership, with the hopes of providing a foundation for our industry to finally turn this dialogue into action.

Featured 3/1/18

The real-world effects of digital health: Announcing the Impact Project

After seven years, we’ve seen $23B invested into thousands of digital health companies. But we wanted to know: what has been the real-world impact of digital health? We were moved to learn just how many lives had been significantly changed by a new wave of technology. We aim to shift the digital health dialogue from one focused on the degree of investment and future expectations to one about digital health’s effect on patients and healthcare outcomes. In that spirit, this ongoing project brings you stories of people living far outside Silicon Valley and the companies shifting the healthcare status quo who have made an impact on their lives.

Featured 2/20/18

Demystifying AI and Machine Learning in Healthcare

AI in healthcare feels inevitable: Optimists predict that artificial intelligence and machine learning (AI/ML) will diagnose disease better and earlier, treat illness more precisely, and engage patients more efficiently than today’s healthcare system does. On top of this, AI/ML is expected to streamline business operations and restore sanity (and humanity) to the clinician experience. To separate hype from reality, read our 50-page white paper, Demystifying AI and Machine Learning in Healthcare.

×